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Abstract 
Although new medications and treatments for Cystic Fibrosis (CF) have been 
developed during the past 20 years, behavioral components of medical treatment 
for CF have been relatively unexplored in prior research. Behavioral components 
that are critical for optimal health include compliance with medications and 
dietary recommendations, and regular physical exercise.  Physicians prescribe 
treatment regimens to patients with CF, but relatively little is known about factors 
associated with performing the prescribed health-related behaviors. Of particular 
interest are psychosocial factors that may influence behavioral compliance 
including self-efficacy (perceived ability to adapt to disease), perceived stigma 
(influence of perceived negative reactions from peer group), and quality of life 
(adaptation to illness in both mental and physical domains).  It was hypothesized 
that patients who exercise regularly, adhere to medications and treatments, and 
maintain healthy dietary habits would report higher quality of life, less perceived 
stigma, and better overall health than those who were not compliant with 
behavioral recommendations. Fifty adolescents and young adults (mean age = 
19.2 years; age range: 15 to 25 years) with CF were recruited from an outpatient 
hospital-based clinic. Participants completed self-report measures of self-
efficacy, stigma, and quality of life, as well as measures of compliance with 
prescribed medications, exercise behavior, and dietary behavior. Higher self-
reported medication adherence was associated with better overall quality of life 
(r=0.27; p= 0.059). In addition, perceived stigma was associated with greater 
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levels of activity (r=0.37, p=0.013). Thus, there was a trend for adherence to be 
associated with better quality of life. Surprisingly, greater levels of activity were 
associated with more perceived stigma. However, this may result from active 
individuals being exposed to more experiences with peers that may be 
stigmatizing. It will be important to identify strategies to help reduce or avoid 
perceived stigma among active patients with CF. 
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Introduction 
Cystic Fibrosis (CF) is a life-threatening genetic mutation occurring on 
chromosome 7 (Gene Gateway, 2003) that affects primarily Caucasians. 
However, this genetic disease is becoming more prevalent in other ethnicities, 
such as Hispanics and African Americans. There are roughly 30,000 Americans 
living with Cystic Fibrosis. This mutation results in progressive respiratory 
deterioration that results from mucus inspissation in the air. The disease also has 
negative effects on the pancreas, where inspissated mucus blocks pancreatic 
ducts, preventing natural digestive enzymes from being released into the 
intestine effectively. Thus, poor growth and weight gain are common among CF 
patients despite a calorie dense diet.  The reproductive system – especially of 
males – also is negatively affected. The disease has historically been highly 
lethal, with the normal lifespan of an individual with CF being less than 10 years 
in the 1950s. However, expected lifespan has dramatically risen since then with 
the predicted mean lifespan presently in the upper-30s for individuals with the 
disease (Cystic Fibrosis Foundation, 2009), and with individuals with CF living 
into their 50s and 60s. This increase in lifespan is due to advancements in 
medication and therapies, all of which require adherence and self-monitoring.  
Patients with CF typically are given various treatments to follow (e.g. 
albuterol, tobramyacin, hypertonic saline, physical therapy) in order to expel 
mucus secretions produced, combat airway infection, and preserve lung function. 
Nebulized treatments are liquid medications that are inhaled into the lungs. 
Physical treatments consist of pulmonary percussion that can be achieved in 
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several ways, such as cupping the hand and pounding the front and back of a 
patient in order to loosen mucus in the lungs. In addition, there is also a machine 
that accomplishes this more effectively than pounding with the hand. Patients are 
also given enzyme tablets to assist the pancreas in digesting food, and there are 
vitamins prescribed for patients to ensure that daily doses of vitamins are 
ingested. Most recently, exercise has become a treatment for controlling CF. 
Taking part in organized regimens of light-to-moderate exercise (e.g. walking, 
stationary bicycling, light weight-lifting) has proven beneficial for patients with CF 
(Mayo Clinic, 2008).  
 Adherence to medication is paramount to treatment of most diseases. In 
order to successfully adhere to medications, individuals must comply in a 
cooperative way with the physician or health care provider to the prescribed 
medications (Taddeo, Egedy, Frappier, 2008). The extensive treatment regimens 
required of patients with CF unfortunately may decrease the likelihood of 
adherence (Zemanick, et al. 2009). Control of CF requires taking many different 
medications. The education level of patients and their families can also influence 
adherence rates. Patients and families with lower education may fail to recognize 
the importance of adherence to medications in the presence of a deadly disease, 
and this may lead to advanced disease progression (Zemanick, et al. 2009). CF 
adolescents are faced with the greatest adherence challenges due to already 
being under significant academic and social strains as adolescents. Academic 
and social stresses are often the most salient stressors in standard adolescent 
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life, but these strains are augmented in adolescents with CF due to pulmonary 
treatment demands (Zemanick, et al 2009).  
 Exercise and diet also are important to patients with CF. Maintaining a 
healthy diet and consistent exercise program can produce greater lung function 
and increased cardio-respiratory system function (Wilkes et al 2009). Patients 
with CF achieve the same benefits from exercising as their healthy peers without 
CF. Patients who consistently adhere to exercise routines show greater lung 
function and report a better quality of life (Wilkes et al 2009). Maintaining a strict, 
calorie-dense diet has positive effects on patients with CF. Optimal nutritional 
intake can yield better growth, lung function, and greater rates of survival (Stark, 
Opipari-Arrigan, Quittner, Bean, & Powers, 2010).  
 Patients with CF report feeling little control over CF facilitated treatment 
adherence schedules provided by physicians (Abbott, Dodd, & Webb, 1996). 
Thus, patients with CF do not feel as though they have control over the 
treatments they are given and the procedures for following them. However, adult 
patients with CF who follow prescribed dietary measures report higher self-
efficacy (i.e. positive feeling of control over one’s self) and improved nutritional 
status (Watson, Bilton, Truby, 2008). CF adolescents who participate in exercise 
training programs have experienced beneficial effects in oxygen consumption, 
muscle force, and improved self-efficacy (Gulmans, Meer, Brackel, Faber, 
Berger, Helders, 1999). Research suggests that exercise training and its benefits 
contribute to improved self-efficacy and overall quality of life.  
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However, there are unique obstacles in treating adolescents with CF due 
to developmental changes in growth and psychosocial functioning that normally 
occur in adolescence. These extreme changes during adolescence may require 
novel approaches by doctors in prescribing new medications and treatments to 
adolescents with CF (Segal, 2008). Adolescents and adults with CF have rates of 
depression/anxiety ranging from 29%-46% (Zemanick, et al. 2009). Patients with 
CF who have anxiety and depression have worse lung function and more 
prominent symptoms of the disease than those patients without anxiety and 
depression (Cruz, Marciel, Quittner, & Schecter, 2009). It has been found that 
adolescents with CF are more affected by anxiety, as reflected in a significant 
negative correlation between anxiety and lung function (Bregnballe, Thastum, & 
Schiøtz, 2007). In addition, adherence may be significantly affected by anxiety 
and depression. Feelings of low motivation and stress may be induced by 
depression and anxiety and are related to poor adherence (Cruz, Marciel, 
Quittner, & Schecter, 2009). Anxiety and depression also contribute to a lower 
quality of life in patients with chronic diseases. CF adolescents, however, have 
the greatest possibility of having anxiety and depression affect both physical and 
mental health factors (Cruz, Marciel, Quittner, and Schecter 2009). During these 
years, the adolescent may experience different phases of attitudes toward the 
disease and how it should be managed. 
Relationships with peers are established and reinforced during 
adolescence, and it is also common to experience academic pressure to 
succeed. However, transient attitudes displayed by adolescents with CF may 
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result in perceived stigma. Stigma is defined as feeling as though one is 
discriminated against, isolated, or rejected by peers due to a defining 
characteristic. Goffman (1963) classified stigma into several different categories, 
one of which is a “spoiled identity” that can include having a shortened life 
expectancy or having a genetic condition that may result in undesirable personal 
characteristics, which is particularly applicable to CF patients. The “undesirable 
characteristics” of CF would be the consistent cough and poor caloric absorption, 
which results in a thin physical appearance that may make patients feel self-
conscious and further isolate them from their peers. The need to take pills in 
public, such as enzymes with meals, or using an inhaler in front of peers also 
may cause patients with CF to withdraw from their peers. There have been few 
studies exploring the effects of stigma on populations with chronic illnesses, and 
no prior studies have evaluated patients with CF. However, Pizzignacco, de 
Mello and de Lima (2010) found in a recent study that adherence to daily 
therapies may be reduced due to interference with social activities with peers. 
Demands of therapies can create a feeling of isolation as well as contribute to 
perceived stigma among patients with CF, especially in the adolescent 
population with CF. Experiencing stigma during adolescence could drastically 
influence how adolescents with CF cope with their disease. Feeling cast out from 
their peer group may cause these individuals to not adhere to medications and 
treatments in order to fit in with their peers.  
Patients with CF may experience resentment toward the disease, and 
adolescents especially may feel that the disease should not be affecting them. As 
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a result, they may proceed to live as though it is not affecting them (i.e., not 
adhering to medications and therapies). By not following these routines, patients 
with CF risk experiencing a decline in pulmonary function, a drop in weight, and 
overall deterioration of physical function. The majority of adolescents with CF 
begin adolescence with normal lung function and good nutrition, primarily due to 
the role of the parents. After adolescence, along with natural factors, the health 
of many CF patients rapidly declines due to decreased role of the parents, who 
attribute a greater role of responsibility to their children.  
 This cross-sectional study is designed to evaluate factors associated with 
self-reported treatment adherence among adolescent and young adult (15-25 
years) patients with CF. This study examines correlations of adherence (to 
medications, diet, and exercise regimens/routines) with perceived stigma, 
anxiety/depression, and overall quality of life. It is hypothesized that patients with 
greater overall adherence will report lower perceived stigma, lower 
anxiety/depression, and higher overall quality of life.  
Methods 
Participants 
Fifty adolescent and young adult patients with Cystic Fibrosis (CF) were 
recruited from the Cystic Fibrosis Clinic at Nationwide Children’s Hospital, 
Columbus, Ohio during regularly scheduled appointments. The sample size of 
the population of target patients at Nationwide Children’s Hospital is over 140 
active patients. The majority of the sample is Caucasian, as that is the group 
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most affected by the disease. Males and females were recruited in approximately 
equal numbers, as shown in Table 1.  
All patients signed informed consent. Patients 18 years and older signed 
an independent consent form, and those under 18 years required a parent or 
guardian to provide written consent.  
Upon consent, patients were provided with a questionnaire packet that 
included measures of demographics, adherence, depression/anxiety, mastery, 
optimism, stigma, and a CF-specific quality of life questionnaire. Body mass 
index (BMI), number of recent hospitalizations, and co-morbid conditions were 
obtained from patient medical records.  
Upon completion of the survey, participants received a $5 Target gift card.  
Measures 
Medications and Therapy Adherence 
 A self-report questionnaire measuring adherence was developed for the 
study. Patients reported amount of time prescribed for both physical and 
nebulized treatments and also reported the amount of time spent adhering to the 
prescribed treatments. Self-reported time was then divided by the prescribed 
time to provide a percent-value reflecting adherence. Adherence was calculated 
for both nebulized medication and physical therapy. Participants also reported 
adherence to prescribed diets and dietary supplements prescribed by physicians 
as well as their confidence in being able to successfully adhere to the 
medications over the span of several weeks. Adherence scores were calculated 
for physical therapy adherence (e.g. Vest adherence) and nebulized adherence 
CF Adolescent Quality of Life 11 
(e.g. inhaled treatments), as well as dietary supplements (e.g. vitamins and 
enzymes) measured in two separate scores.   
Physical Activity  
 Physical activity was assessed with a 7-day activity record (Blair, Haskell, 
Ho, 1985). Activities were categorized as mild, moderate, or intense physical 
activity, with examples of each category provided to respondents. Participants 
marked the level of activity performed each day and the amount of time spent 
performing the physical activity. Confidence in performing physical activity was 
also recorded as a measure of self-efficacy.  
Physical and Social Activity 
 Amount of physical and social activity was measured using a 
questionnaire developed for this study. Participants were given a list of activities, 
classified as social (“hanging out” with friends, doing well academically, having 
hobbies, extracurricular activities) or physical (playing sports, taking family 
vacations, having a job, camping). Participants then indicated on a Likert scale 
from 1 to 4, how much they were impeded from these activities due to CF. A total 
score was computed from all ratings (with Not Applicable being a zero). Two 
subscores also were computed to reflect social and physical activities.  
CF specific Quality of Life 
 The Cystic Fibrosis Questionnaire-Revised (CFQ-R; Quittner, Buu, 
Messer, Modi, & Watrous, 2005) was included to assess physical, social, and 
emotional aspects of CF, treatment burden, and health perceptions. The 
measure is designed for CF patients age 14 and older.  
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Anxiety and Depression 
 Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) 
was used to measure symptoms of depression and anxiety. The measure 
includes 7 self-report items assessing anxiety and 7 items assessing depression. 
Each item is rated on a 4-point Likert scale.  
Mastery 
 Perceived control was measured with Pearlin and Schooler’s (1978) 
seven-item Personal Mastery Scale. Each of the seven statements is rated on a 
4-point Likert scale, ranging from 0 (Strongly Disagree) to 3 (Strongly Agree), 
with some items reverse scored.  
Stigma 
 Fife and Wright’s (Fife & Wright, 2000) Social Impact Scale (SIS) includes 
24 items evaluating stigma among patients coping with a chronic illness. A total 
score and four subscale scores are calculated: social rejection, financial 
insecurity, internalized shame, and social isolation. The financial insecurity 
subscale was modified to reflect academic insecurity because most participants 
were attending an academic institution during the study. Each item on the scale 
is rated on a four-point Likert scale ranging from 1 (Strongly Disagree) to 4 
(Strongly Agree) and also includes a “not applicable” option.  
Data Analysis 
 Data were analyzed with Pearson correlations and analyses of variance 
(ANOVAs). Correlations examined the relationship of treatment adherence and 
confidence to quality of life, stigma, anxiety, depression, mastery, and overall 
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activity. To evaluate the relationship between illness severity and outcomes, the 
sample was divided into two groups: less severe patients with FEV1% predicted 
at or above the 80th percentile vs. patients with more severe illness. ANOVA was 
then conducted for adherence measures and other psychosocial variables using 
illness severity as the between subjects factor.  
Results 
 Nebulized (e.g. inhaled medications) adherence was positively correlated 
with physical therapy adherence (r = 0.58; p <0.001) and enzyme adherence  
(r = 0.34; p = 0.017), as well as negatively correlated with the HADS total  
(r = -0.31; p = 0.037), and with the anxiety subscale (r = -0.32; p = 0.023), as 
shown in Table 2. Overall, stigma was not associated with nebulized treatment 
adherence. However, analysis of subscales indicated that the financial/academic 
insecurity was negatively correlated with nebulized adherence (r = -0.33; p = 
0.020). Nebulized adherence was not associated with quality of life or mastery. 
 Physical therapy adherence was not significantly correlated with any 
psychosocial variables, but was correlated with enzyme (r = 0.42; p = 0.003) and 
diet (r = 0.34; p = 0.021) adherence. Physical therapy adherence was positively 
associated with confidence in engaging in physical activity (r = 0.34; p = 0.019). 
 Dietary adherence was not correlated with any other variables. Exercise 
adherence also was not correlated with psychosocial variables.   
 Total activity (social and physical combined) was negatively correlated 
with several CF quality of life measures, physical (r = -0.33; p = 0.026), emotional 
(r = -0.39; p = 0.007), and treatment (r = -0.35; p = 0.017), as shown in Table 3. 
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Thus, greater activity was associated with worse quality of life in physical, 
emotional, and treatment burden domains. Total activity was correlated with 
HADS total score (r = 0.34; p = 0.027) and with the anxiety subscale score (r = 
0.32; p = 0.031). Subscale analyses indicated that social activity was associated 
with anxiety (r = 0.38; p = 0.008), and with depression (r = 0.30; p = 0.047). Total 
activity also was associated with SIS total (r = 0.32; p = 0.03), as shown in Table 
4. Among SIS subscales, only social rejection was associated with activity (r = 
0.35; p = 0.019).  
Physical quality of life was associated with less social rejection (r=  -0.49; 
p= 0.0004), less financial/academic insecurity (r= -0.35; p= 0.012), and less 
social isolation (r= -0.44; p= 0.00014). Emotional quality of life was associated 
with less social rejection (r= -0.45; p= 0.0013), less financial/academic insecurity 
(r= -0.49; p= 0.0003), and less social isolation (r= -0.67; p= <0.0001). Social 
quality of life was associated with less social rejection (r= -0.49; p= 0.0003), less 
financial/academic insecurity (r= -0.31; p= 0.029), less internalized shame (r=      
-0.42; p= 0.0026), and less social isolation (r= -0.56; p= <0.0001). Total activity 
also was associated with social rejection and financial/academic insecurity 
(dimension 1) of the SIS scale (r = 0.37; p = 0.013). 
 Self-reported confidence in performing nebulized and physical therapy 
revealed a positive correlation (r = 0.86; p <0.0001) with nebulized adherence. 
Reported dietary confidence also was associated with enzyme and vitamin 
adherence confidence (r = 0.48; p = 0.003).  
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Exercise confidence was positively associated with perceiving one’s 
health as being better than that of peers without CF (r = 0.39; p = 0.005) and that 
of peers with CF (r = 0.40; p = 0.004). Greater exercise confidence also was 
associated with lower HADS total score (r = -0.63; p <0.0001), and with lower 
anxiety (r = -0.33; p = 0.019) and depression (r = -0.75; p <0.0001), as well as 
lower stigma (r = -0.32; p = 0.029). Greater experienced and perceived stigma 
were associated with lower exercise confidence. In particular, social rejection 
was associated with lower exercise confidence (r = -0.34; p = 0.019). Greater 
exercise confidence was associated with higher CF quality of life - emotion (r 
=0.45; p = 0.001), with social quality of life (r = 0.51; p = 0.0001), and with CF 
quality of body (r = 0.44; p = 0.001), physical (r = 0.60; p <0.0001), and vitality (r 
= 0.60; p <0.0001).  
As shown in Table 5, participants with less severe disease, indicated by 
FEV1% scores at or above the 80th percentile, had significantly higher scores on 
CFQ-R physical (p = 0.008), vitality (p = 0.036), and body (p = 0.013). However, 
there were no illness severity differences in CF quality of life subscales of 
emotion, social, diet, and treatment burden. In addition, there was no group 
difference in stigma or in nebulized or physical therapy adherence. There was a 
trend on depression (p = 0.095) indicating that patients with less severe disease 
report less depression than those with more severe disease. However, there was 
no group difference for anxiety. Patients with less severe disease are more likely 
than patients with more severe disease to view their health as good as or better 
than peers their age without CF (F = 15.96, p = 0.0002) and compared to peers 
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with CF (F = 24.87; p <.0001). Exercise confidence also demonstrated a trend 
reflecting that patients with less severe disease appeared to have greater 
exercise confidence than others (F = 3.73, p = 0.059). There was no illness 
severity effect for enzyme and vitamin adherence.  
Discussion 
 Self-reported treatment adherence, both to physical therapy and 
medications, was associated with better self-reported physical functioning. This 
may be a result of the treatment effects on the lungs and other treatment target 
areas (e.g. pancreas, sinuses, bowels), allowing individuals to feel less fatigued. 
Adherence to medication was associated with less anxiety and less 
financial/academic insecurity. Adhering to medication may cause patients to 
display fewer symptoms, decreasing the chance that they display aspects of CF 
that may cause anxiety or insecurity. However, treatment adherence was not 
associated with CF-specific quality of life measures. Although it was expected 
that medication adherence would be associated with fewer symptoms of CF and 
thus be associated with a more “normal” life and better quality of life, the results 
did not support the hypothesis. Adolescent asthma patients have been studied, 
reporting that the more asthma symptoms one had, the greater the levels of 
anxiety experienced (McGrady, et. al., 2011). These findings may indicate that 
treatment and screening for anxiety may result in improved treatment adherence 
and decreased anxiety. Addressing this finding in CF patients may also result in 
improved treatment adherence and decreased anxiety.  
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 Nebulized adherence was associated with less anxiety and depression. 
The effects of nebulized adherence (i.e. creating cleaner airways and reduced 
pulmonary obstructions) may cause individuals to be less anxious around peers 
and also feel better about their health as a result of the medication. Although 
physical therapy adherence was not associated with anxiety or depression, it 
may be that other forms of physical therapy (e.g. running, weight training, sports) 
may have a greater association with anxiety and depression. Diet adherence was 
not associated with anxiety or depression. Exercise confidence also was 
associated with less anxiety and depression. Higher self-efficacy regarding the 
performance of exercise and sports may reduce anxiety and depression amongst 
individuals with CF because the capability to perform exercise may indicate that 
individuals with CF are at the same level as their peers without CF. Overall 
activity level was positively correlated with anxiety and, to a lesser degree, with 
depression. Increased activity may be associated with anxiety and depression 
due to patients taking part in physical and social activities among peers without 
CF. This may, in turn, lead to patients feeling self-conscious about performing 
any CF related behavior (e.g. coughing up mucus, taking enzymes, puffing 
inhaler) in front of peers, thus contributing to anxiety around friends. Depression 
may result from active individuals with CF perceiving differences between 
themselves and their peers without CF. However; patients who are naturally 
inclined toward anxiety may feel compelled to engage in more activity. The 
association with anxiety and depression was of greater magnitude in the domain 
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of social activity. This may be due to more regular comparisons being made 
during social activity.   
Lower financial/academic insecurity was associated with greater nebulized 
adherence. This indicates adherence to nebulized treatments may have a 
positive influence on financial/academic insecurities. Physical therapy adherence 
and dietary adherence were not associated with stigma. This result may exist 
because the diet and some physical therapy (e.g. exercise) are the same as 
individuals without CF. Stigma was negatively correlated with exercise behavior 
confidence, indicating that increased exercise confidence was associated with 
decreased perceived stigma. This relation demonstrates a possibility that 
patients who believe they have the capacity to perform physical activity 
experience less negative judgment from their peers. The social rejection variable 
was negatively correlated with exercise confidence as well; indicating that greater 
confidence in performing exercise behavior was associated with less social 
rejection. With increased social confidence around peers, individuals with CF 
may not feel as though peers are as likely to stigmatize them. Surprisingly, total 
activity was associated with greater stigma. It is possible that active CF patients 
experience more opportunities for being judged by their peers without CF. Total 
activity was associated with reduced CF quality of life (physical, emotional, and 
treatment) demonstrates this point. Increased interaction with peers may lead to 
feeling inadequate compared to peers, thus promoting a decrease in quality of 
life. Also, more activity performed by CF patients may lead to less time allotted 
for medication, which may be the cause for the decrease in treatment burden 
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reported by participants. These results are similar to those seen in modern 
asthma studies, in which adolescents with asthma had much greater social 
anxiety than peers without asthma. Bruzzese et al. (2009) found that adolescent 
asthma patients had increased anxiety in social settings and feared social 
rejection and isolation for any medical symptoms and/or behaviors. These 
findings may suggest common sources of anxiety in both CF and asthma 
adolescents. Preventative measures that have been developed to address social 
anxiety in adolescent asthma patients may be useful among adolescent CF 
patients as well.  
 Adhering to medications was expected to be associated with a better 
quality of life because the disease can be devastating without proper treatment. 
However, performing medical procedures to remain healthy may generate a 
feeling of discontent, therein producing a lower quality of life. Diet was not 
significantly correlated with CF specific quality of life. CF specific quality of life 
correlated positively with exercise behavior confidence, showing that greater 
confidence in ability to engage in physical activity is related to better quality of 
life. CF quality of emotion (feelings of emotional health) was positively correlated 
with exercise confidence. Perhaps individuals with CF who feel capable of 
performing exercise have an enhanced emotional quality of life due to feeling that 
they can take action in the context of the illness. Exercise confidence was also 
associated with CF social quality of life. Thus, exercise confidence may also 
reflect or facilitate access to social relations. CF quality of life measures of body, 
physical, and vitality all were associated with exercise confidence. Thus having 
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confidence in exercise abilities appears to be related to better body image and 
greater physical quality of life. The ability to perform exercise and the execution 
of exercise are associated with a better sense of overall vitality in daily life as 
well.  
 There are several limitations of this pilot study. The measure of adherence 
was the greatest limitation. Creating a measure that more accurately records 
both nebulized and physical therapy adherence would be important. The current 
study relied on self-report from memory, which is subject to reporting bias. Also, 
correlations with dietary adherence may have been limited due to few CF 
patients in the study having a prescribed diet.  
Future studies to further examine the results and implications of this study 
may promote further understanding. Examining whether treatment for anxiety 
influences nebulized treatment adherence may indicate to physicians that 
addressing anxiety is a way to improve nebulized adherence. The association 
between social activity and distress (i.e., anxiety, depression, and experienced 
stigma) may result from patients being more exposed to circumstances of social 
distress or social comparison. Addressing the influence of social activity and 
positive social interactions may reduce feelings of anxiety and depression and 
experienced stigma. Reducing stigma may occur by encouraging patients to talk 
to peers about specific aspects of the disease that may be salient in relationships 
with peers. Thus, the goal would be to prevent any perceived thoughts of stigma, 
which may result from the perception that peers do not understand the disease. 
Confidence and mastery may also be important intervention targets for improving 
CF Adolescent Quality of Life 21 
adherence and quality of life and reducing feelings of anxiety and depression and 
stigma. Providing ways to maintain confidence under conditions that elicit 
feelings of anxiety and depression may improve quality of life of patients with CF.  
Overall, the data indicate important associations to consider in the care of 
patients with CF. Physicians may want to make patients aware of the positive 
associations with adhering to prescribed medications. Treating patients with 
anxiety and depression may help promote better adherence among affected 
patients by helping patients feel less negative about performing medical 
therapies. This may cause patients to be more adherent to treatments, potentially 
leading to a better overall quality of life. By performing medications at home and 
talking with peers about CF, individuals may also find that performing activities 
with friends will not result in greater perceived stigma. Having a good quality of 
life, low anxiety and depression, and low perceived stigma is paramount to 
enhanced life quality. By promoting treatment adherence, physicians may 
influence young patients with CF to realize that medications do not need to 
detract from doing other activities, but provide a long-term way of enhancing life 
and creating the healthiest life achievable for the individual.   
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Table 1. Demographics of Sample 
(n = 50) 
 n % 
Male 27 54.0 
Living with Parents 34 68.0 
 Mean Sd 
Age 
Range: 15-25 
19.2 3.1 
FEV1% Predicted  78.0% 24.6 
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Table 2. Correlation of psychosocial variables 
with adherence to two therapies 
 Nebulized 
Physical 
Therapy 
Anxiety -0.323* -0.128 
Depression -0.177 -0.258 
Social QoL 0.160 0.119 
Physical QoL 0.135 0.191 
Emotional QoL 0.246 0.159 
Dietary QoL -0.138 -0.076 
Treatment QoL 0.016 -0.110 
Experienced Stigma -0.195 -0.192 
Perceived Stigma -0.124 -0.009 
Mastery 0.151 0.013 
* p< 0.05 ** p< 0.01 *** p< 0.001 
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Table 3: Correlations of activity dimensions and confidence with psychological variables 
 Activity Social Activity Physical 
Activity 
Confidence 
Anxiety 0.323* 0.380** 0.230 -0.332* 
Depression 0.249 0.298* 0.183  -0.754*** 
Social QoL -0.219 -0.128 -0.251 0.508** 
Physical QoL -0.329* -0.245 -0.355* 0.601*** 
Emotional QoL -0.393** -0.315* -0.380** 0.446** 
Dietary QoL 0.037 0.142 -0.077 0.357* 
Treatment QoL -0.351* -0.175 -0.458** 0.182 
Body QoL -0.269 -0.204 -0.240 0.442** 
Vitality -0.125 -0.059 -0.195 0.598*** 
Mastery -0.063 -0.149 -0.013 0.249 
* p< 0.05 ** p< 0.01 *** p< 0.001 
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Table 4. Correlations of stigma with activity dimensions, quality of life, and adherence  
 Experienced 
Stigma 
Perceived 
Stigma 
Social 
Rejection 
Internalized 
Shame 
Social 
Isolation 
Financial/ 
Academic 
Insecurity 
Social 
Activity 
0.303* 0.110 0.277 0.054 0.120 0.253 
Physical 
Activity 
0.333* 0.242 0.348* 0.084 0.280 0.192 
Physical 
QoL 
-0.511*** -0.360* -0.494*** -0.098 -0.440** -0.351* 
Emotional 
QoL 
-0.547*** -0.566*** -0.452** -0.198 -0.666*** -0.487*** 
Social QoL -0.496*** -0.589*** -0.499*** -0.418** -0.565*** -0.308* 
Mastery -0.284 -0.562*** -0.279 -0.454** -0.524*** -0.199 
Exercise 
Confidence 
-0.307* -0.297* -0.338* -0.085 -0.360* -0.147 
Physical  
Adherence 
-0.192 -0.009 -0.164 0.107 -0.077 -0.168 
Nebulized  
Adherence 
-0.195 -0.124 -0.071 -0.018 -0.182 -0.331 
 
* p< 0.05 ** p< 0.01 *** p< 0.001 
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Table 5. Quality of life and adherence by illness severity 
 
Normal Range 
(FEV1% >  80%) 
Impaired Range 
(FEV1% <  80%) 
Treatment QoL 55.1 (22.1) 52.5 (17.8) 
Dietary QoL 92.4 (13.5) 85.8 (18.3) 
Social QoL 74.5 (18.2) 68.2 (18.7) 
Emotion QoL 75.5 (18.4) 70.8 (23.8) 
Physical QoL 84.1 (16.8) 65.9 (26.7)** 
Vitality QoL 62.1 (16.2) 51.2 (19.3)* 
Body QoL 77.3 (18.9) 59.8 (27.3)* 
Exercise Confidence 87.8 (16.9) 74.2 (29.4) 
Self-rated health compared to   
Peers with CF 2.8 (0.40) 1.9 (0.70)*** 
Peers without CF 1.91 (0.68) 1.24 (0.51)*** 
* p< 0.05 ** p< 0.01 *** p< 0.001 
